The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sulphonamides Market Research Report 2025
Synopsis
Sulfonamides (sulphonamides) are a group of man-made (synthetic) medicines that contain the sulfonamide chemical group. They may also be called sulfa drugs. Many people use the term sulfonamide imprecisely to refer only to antibiotics that have a sulfonamide functional group in their chemical structure.
The global Sulphonamides market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sulphonamides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sulphonamides.
Report Scope
The Sulphonamides market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sulphonamides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sulphonamides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Boehringer Ingelheim Pharmaceuticals
Bayer AG
GlaxoSmithKline
King Pharmaceuticals
Mylan Pharmaceuticals
Novartis International AG
Pfizer
Par Pharmaceutical
Roche Holding AG
Sanofi Aventis
Stiefel Laboratories
Segment by Type
Orally Absorbable Sulfonamide
Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
Segment by Application
Skin Infections
Gastro Intestinal Tract (GIT) Infection
Meningitis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sulphonamides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sulphonamides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Sulfonamides (sulphonamides) are a group of man-made (synthetic) medicines that contain the sulfonamide chemical group. They may also be called sulfa drugs. Many people use the term sulfonamide imprecisely to refer only to antibiotics that have a sulfonamide functional group in their chemical structure.
The global Sulphonamides market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sulphonamides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sulphonamides.
Report Scope
The Sulphonamides market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sulphonamides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sulphonamides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Boehringer Ingelheim Pharmaceuticals
Bayer AG
GlaxoSmithKline
King Pharmaceuticals
Mylan Pharmaceuticals
Novartis International AG
Pfizer
Par Pharmaceutical
Roche Holding AG
Sanofi Aventis
Stiefel Laboratories
Segment by Type
Orally Absorbable Sulfonamide
Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
Segment by Application
Skin Infections
Gastro Intestinal Tract (GIT) Infection
Meningitis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sulphonamides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sulphonamides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Sulphonamides Market Overview
1.1 Product Overview and Scope of Sulphonamides
1.2 Sulphonamides Segment by Type
1.2.1 Global Sulphonamides Market Value Comparison by Type (2024-2030)
1.2.2 Orally Absorbable Sulfonamide
1.2.3 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
1.2.4 Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
1.3 Sulphonamides Segment by Application
1.3.1 Global Sulphonamides Market Value by Application: (2024-2030)
1.3.2 Skin Infections
1.3.3 Gastro Intestinal Tract (GIT) Infection
1.3.4 Meningitis
1.4 Global Sulphonamides Market Size Estimates and Forecasts
1.4.1 Global Sulphonamides Revenue 2019-2030
1.4.2 Global Sulphonamides Sales 2019-2030
1.4.3 Global Sulphonamides Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Sulphonamides Market Competition by Manufacturers
2.1 Global Sulphonamides Sales Market Share by Manufacturers (2019-2024)
2.2 Global Sulphonamides Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Sulphonamides Average Price by Manufacturers (2019-2024)
2.4 Global Sulphonamides Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sulphonamides, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sulphonamides, Product Type & Application
2.7 Sulphonamides Market Competitive Situation and Trends
2.7.1 Sulphonamides Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sulphonamides Players Market Share by Revenue
2.7.3 Global Sulphonamides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sulphonamides Retrospective Market Scenario by Region
3.1 Global Sulphonamides Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Sulphonamides Global Sulphonamides Sales by Region: 2019-2030
3.2.1 Global Sulphonamides Sales by Region: 2019-2024
3.2.2 Global Sulphonamides Sales by Region: 2025-2030
3.3 Global Sulphonamides Global Sulphonamides Revenue by Region: 2019-2030
3.3.1 Global Sulphonamides Revenue by Region: 2019-2024
3.3.2 Global Sulphonamides Revenue by Region: 2025-2030
3.4 North America Sulphonamides Market Facts & Figures by Country
3.4.1 North America Sulphonamides Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Sulphonamides Sales by Country (2019-2030)
3.4.3 North America Sulphonamides Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sulphonamides Market Facts & Figures by Country
3.5.1 Europe Sulphonamides Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Sulphonamides Sales by Country (2019-2030)
3.5.3 Europe Sulphonamides Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sulphonamides Market Facts & Figures by Country
3.6.1 Asia Pacific Sulphonamides Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Sulphonamides Sales by Country (2019-2030)
3.6.3 Asia Pacific Sulphonamides Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sulphonamides Market Facts & Figures by Country
3.7.1 Latin America Sulphonamides Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Sulphonamides Sales by Country (2019-2030)
3.7.3 Latin America Sulphonamides Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sulphonamides Market Facts & Figures by Country
3.8.1 Middle East and Africa Sulphonamides Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Sulphonamides Sales by Country (2019-2030)
3.8.3 Middle East and Africa Sulphonamides Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sulphonamides Sales by Type (2019-2030)
4.1.1 Global Sulphonamides Sales by Type (2019-2024)
4.1.2 Global Sulphonamides Sales by Type (2025-2030)
4.1.3 Global Sulphonamides Sales Market Share by Type (2019-2030)
4.2 Global Sulphonamides Revenue by Type (2019-2030)
4.2.1 Global Sulphonamides Revenue by Type (2019-2024)
4.2.2 Global Sulphonamides Revenue by Type (2025-2030)
4.2.3 Global Sulphonamides Revenue Market Share by Type (2019-2030)
4.3 Global Sulphonamides Price by Type (2019-2030)
5 Segment by Application
5.1 Global Sulphonamides Sales by Application (2019-2030)
5.1.1 Global Sulphonamides Sales by Application (2019-2024)
5.1.2 Global Sulphonamides Sales by Application (2025-2030)
5.1.3 Global Sulphonamides Sales Market Share by Application (2019-2030)
5.2 Global Sulphonamides Revenue by Application (2019-2030)
5.2.1 Global Sulphonamides Revenue by Application (2019-2024)
5.2.2 Global Sulphonamides Revenue by Application (2025-2030)
5.2.3 Global Sulphonamides Revenue Market Share by Application (2019-2030)
5.3 Global Sulphonamides Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Sulphonamides Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Laboratories Sulphonamides Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Boehringer Ingelheim Pharmaceuticals
6.2.1 Boehringer Ingelheim Pharmaceuticals Corporation Information
6.2.2 Boehringer Ingelheim Pharmaceuticals Description and Business Overview
6.2.3 Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer Ingelheim Pharmaceuticals Sulphonamides Product Portfolio
6.2.5 Boehringer Ingelheim Pharmaceuticals Recent Developments/Updates
6.3 Bayer AG
6.3.1 Bayer AG Corporation Information
6.3.2 Bayer AG Description and Business Overview
6.3.3 Bayer AG Sulphonamides Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer AG Sulphonamides Product Portfolio
6.3.5 Bayer AG Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Sulphonamides Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GlaxoSmithKline Sulphonamides Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 King Pharmaceuticals
6.5.1 King Pharmaceuticals Corporation Information
6.5.2 King Pharmaceuticals Description and Business Overview
6.5.3 King Pharmaceuticals Sulphonamides Sales, Revenue and Gross Margin (2019-2024)
6.5.4 King Pharmaceuticals Sulphonamides Product Portfolio
6.5.5 King Pharmaceuticals Recent Developments/Updates
6.6 Mylan Pharmaceuticals
6.6.1 Mylan Pharmaceuticals Corporation Information
6.6.2 Mylan Pharmaceuticals Description and Business Overview
6.6.3 Mylan Pharmaceuticals Sulphonamides Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mylan Pharmaceuticals Sulphonamides Product Portfolio
6.6.5 Mylan Pharmaceuticals Recent Developments/Updates
6.7 Novartis International AG
6.6.1 Novartis International AG Corporation Information
6.6.2 Novartis International AG Description and Business Overview
6.6.3 Novartis International AG Sulphonamides Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis International AG Sulphonamides Product Portfolio
6.7.5 Novartis International AG Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Sulphonamides Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pfizer Sulphonamides Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Par Pharmaceutical
6.9.1 Par Pharmaceutical Corporation Information
6.9.2 Par Pharmaceutical Description and Business Overview
6.9.3 Par Pharmaceutical Sulphonamides Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Par Pharmaceutical Sulphonamides Product Portfolio
6.9.5 Par Pharmaceutical Recent Developments/Updates
6.10 Roche Holding AG
6.10.1 Roche Holding AG Corporation Information
6.10.2 Roche Holding AG Description and Business Overview
6.10.3 Roche Holding AG Sulphonamides Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Roche Holding AG Sulphonamides Product Portfolio
6.10.5 Roche Holding AG Recent Developments/Updates
6.11 Sanofi Aventis
6.11.1 Sanofi Aventis Corporation Information
6.11.2 Sanofi Aventis Sulphonamides Description and Business Overview
6.11.3 Sanofi Aventis Sulphonamides Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sanofi Aventis Sulphonamides Product Portfolio
6.11.5 Sanofi Aventis Recent Developments/Updates
6.12 Stiefel Laboratories
6.12.1 Stiefel Laboratories Corporation Information
6.12.2 Stiefel Laboratories Sulphonamides Description and Business Overview
6.12.3 Stiefel Laboratories Sulphonamides Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Stiefel Laboratories Sulphonamides Product Portfolio
6.12.5 Stiefel Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sulphonamides Industry Chain Analysis
7.2 Sulphonamides Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sulphonamides Production Mode & Process
7.4 Sulphonamides Sales and Marketing
7.4.1 Sulphonamides Sales Channels
7.4.2 Sulphonamides Distributors
7.5 Sulphonamides Customers
8 Sulphonamides Market Dynamics
8.1 Sulphonamides Industry Trends
8.2 Sulphonamides Market Drivers
8.3 Sulphonamides Market Challenges
8.4 Sulphonamides Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Sulphonamides Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Sulphonamides Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Sulphonamides Market Competitive Situation by Manufacturers in 2023
Table 4. Global Sulphonamides Sales (K MT) of Key Manufacturers (2019-2024)
Table 5. Global Sulphonamides Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Sulphonamides Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Sulphonamides Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Sulphonamides Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Sulphonamides, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Sulphonamides, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Sulphonamides, Product Type & Application
Table 12. Global Key Manufacturers of Sulphonamides, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sulphonamides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sulphonamides as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sulphonamides Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Sulphonamides Sales by Region (2019-2024) & (K MT)
Table 18. Global Sulphonamides Sales Market Share by Region (2019-2024)
Table 19. Global Sulphonamides Sales by Region (2025-2030) & (K MT)
Table 20. Global Sulphonamides Sales Market Share by Region (2025-2030)
Table 21. Global Sulphonamides Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Sulphonamides Revenue Market Share by Region (2019-2024)
Table 23. Global Sulphonamides Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Sulphonamides Revenue Market Share by Region (2025-2030)
Table 25. North America Sulphonamides Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Sulphonamides Sales by Country (2019-2024) & (K MT)
Table 27. North America Sulphonamides Sales by Country (2025-2030) & (K MT)
Table 28. North America Sulphonamides Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Sulphonamides Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Sulphonamides Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Sulphonamides Sales by Country (2019-2024) & (K MT)
Table 32. Europe Sulphonamides Sales by Country (2025-2030) & (K MT)
Table 33. Europe Sulphonamides Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Sulphonamides Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Sulphonamides Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Sulphonamides Sales by Region (2019-2024) & (K MT)
Table 37. Asia Pacific Sulphonamides Sales by Region (2025-2030) & (K MT)
Table 38. Asia Pacific Sulphonamides Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Sulphonamides Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Sulphonamides Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Sulphonamides Sales by Country (2019-2024) & (K MT)
Table 42. Latin America Sulphonamides Sales by Country (2025-2030) & (K MT)
Table 43. Latin America Sulphonamides Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Sulphonamides Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Sulphonamides Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Sulphonamides Sales by Country (2019-2024) & (K MT)
Table 47. Middle East & Africa Sulphonamides Sales by Country (2025-2030) & (K MT)
Table 48. Middle East & Africa Sulphonamides Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Sulphonamides Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Sulphonamides Sales (K MT) by Type (2019-2024)
Table 51. Global Sulphonamides Sales (K MT) by Type (2025-2030)
Table 52. Global Sulphonamides Sales Market Share by Type (2019-2024)
Table 53. Global Sulphonamides Sales Market Share by Type (2025-2030)
Table 54. Global Sulphonamides Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Sulphonamides Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Sulphonamides Revenue Market Share by Type (2019-2024)
Table 57. Global Sulphonamides Revenue Market Share by Type (2025-2030)
Table 58. Global Sulphonamides Price (USD/MT) by Type (2019-2024)
Table 59. Global Sulphonamides Price (USD/MT) by Type (2025-2030)
Table 60. Global Sulphonamides Sales (K MT) by Application (2019-2024)
Table 61. Global Sulphonamides Sales (K MT) by Application (2025-2030)
Table 62. Global Sulphonamides Sales Market Share by Application (2019-2024)
Table 63. Global Sulphonamides Sales Market Share by Application (2025-2030)
Table 64. Global Sulphonamides Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Sulphonamides Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Sulphonamides Revenue Market Share by Application (2019-2024)
Table 67. Global Sulphonamides Revenue Market Share by Application (2025-2030)
Table 68. Global Sulphonamides Price (USD/MT) by Application (2019-2024)
Table 69. Global Sulphonamides Price (USD/MT) by Application (2025-2030)
Table 70. Abbott Laboratories Corporation Information
Table 71. Abbott Laboratories Description and Business Overview
Table 72. Abbott Laboratories Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 73. Abbott Laboratories Sulphonamides Product
Table 74. Abbott Laboratories Recent Developments/Updates
Table 75. Boehringer Ingelheim Pharmaceuticals Corporation Information
Table 76. Boehringer Ingelheim Pharmaceuticals Description and Business Overview
Table 77. Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 78. Boehringer Ingelheim Pharmaceuticals Sulphonamides Product
Table 79. Boehringer Ingelheim Pharmaceuticals Recent Developments/Updates
Table 80. Bayer AG Corporation Information
Table 81. Bayer AG Description and Business Overview
Table 82. Bayer AG Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Bayer AG Sulphonamides Product
Table 84. Bayer AG Recent Developments/Updates
Table 85. GlaxoSmithKline Corporation Information
Table 86. GlaxoSmithKline Description and Business Overview
Table 87. GlaxoSmithKline Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. GlaxoSmithKline Sulphonamides Product
Table 89. GlaxoSmithKline Recent Developments/Updates
Table 90. King Pharmaceuticals Corporation Information
Table 91. King Pharmaceuticals Description and Business Overview
Table 92. King Pharmaceuticals Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. King Pharmaceuticals Sulphonamides Product
Table 94. King Pharmaceuticals Recent Developments/Updates
Table 95. Mylan Pharmaceuticals Corporation Information
Table 96. Mylan Pharmaceuticals Description and Business Overview
Table 97. Mylan Pharmaceuticals Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. Mylan Pharmaceuticals Sulphonamides Product
Table 99. Mylan Pharmaceuticals Recent Developments/Updates
Table 100. Novartis International AG Corporation Information
Table 101. Novartis International AG Description and Business Overview
Table 102. Novartis International AG Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. Novartis International AG Sulphonamides Product
Table 104. Novartis International AG Recent Developments/Updates
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 108. Pfizer Sulphonamides Product
Table 109. Pfizer Recent Developments/Updates
Table 110. Par Pharmaceutical Corporation Information
Table 111. Par Pharmaceutical Description and Business Overview
Table 112. Par Pharmaceutical Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 113. Par Pharmaceutical Sulphonamides Product
Table 114. Par Pharmaceutical Recent Developments/Updates
Table 115. Roche Holding AG Corporation Information
Table 116. Roche Holding AG Description and Business Overview
Table 117. Roche Holding AG Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 118. Roche Holding AG Sulphonamides Product
Table 119. Roche Holding AG Recent Developments/Updates
Table 120. Sanofi Aventis Corporation Information
Table 121. Sanofi Aventis Description and Business Overview
Table 122. Sanofi Aventis Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 123. Sanofi Aventis Sulphonamides Product
Table 124. Sanofi Aventis Recent Developments/Updates
Table 125. Stiefel Laboratories Corporation Information
Table 126. Stiefel Laboratories Description and Business Overview
Table 127. Stiefel Laboratories Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 128. Stiefel Laboratories Sulphonamides Product
Table 129. Stiefel Laboratories Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Sulphonamides Distributors List
Table 133. Sulphonamides Customers List
Table 134. Sulphonamides Market Trends
Table 135. Sulphonamides Market Drivers
Table 136. Sulphonamides Market Challenges
Table 137. Sulphonamides Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Sulphonamides
Figure 2. Global Sulphonamides Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Sulphonamides Market Share by Type in 2023 & 2030
Figure 4. Orally Absorbable Sulfonamide Product Picture
Figure 5. Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) Product Picture
Figure 6. Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide) Product Picture
Figure 7. Global Sulphonamides Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Sulphonamides Market Share by Application in 2023 & 2030
Figure 9. Skin Infections
Figure 10. Gastro Intestinal Tract (GIT) Infection
Figure 11. Meningitis
Figure 12. Global Sulphonamides Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Sulphonamides Market Size (2019-2030) & (US$ Million)
Figure 14. Global Sulphonamides Sales (2019-2030) & (K MT)
Figure 15. Global Sulphonamides Average Price (USD/MT) & (2019-2030)
Figure 16. Sulphonamides Report Years Considered
Figure 17. Sulphonamides Sales Share by Manufacturers in 2023
Figure 18. Global Sulphonamides Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Sulphonamides Players: Market Share by Revenue in 2023
Figure 20. Sulphonamides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Sulphonamides Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Sulphonamides Sales Market Share by Country (2019-2030)
Figure 23. North America Sulphonamides Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Sulphonamides Sales Market Share by Country (2019-2030)
Figure 27. Europe Sulphonamides Revenue Market Share by Country (2019-2030)
Figure 28. Germany Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Sulphonamides Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Sulphonamides Revenue Market Share by Region (2019-2030)
Figure 35. China Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Sulphonamides Sales Market Share by Country (2019-2030)
Figure 46. Latin America Sulphonamides Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Sulphonamides Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Sulphonamides Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Sulphonamides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Sulphonamides by Type (2019-2030)
Figure 56. Global Revenue Market Share of Sulphonamides by Type (2019-2030)
Figure 57. Global Sulphonamides Price (USD/MT) by Type (2019-2030)
Figure 58. Global Sales Market Share of Sulphonamides by Application (2019-2030)
Figure 59. Global Revenue Market Share of Sulphonamides by Application (2019-2030)
Figure 60. Global Sulphonamides Price (USD/MT) by Application (2019-2030)
Figure 61. Sulphonamides Value Chain
Figure 62. Sulphonamides Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
